![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Press Releases
AMRI Announces Development and Commercial Supply Agreement with Parnell Manufacturing
AMRI announced that it has entered into a development and long term exclusive commercial supply agreement with Parnell Manufacturing Pty Ltd (Parnell), an Australian...
Press Releases
Lundbeck’s partner Mochida receives approval of Lexapro in Japan
H. Lundbeck A/S announced that our partner Mochida Pharmaceutical Co., Ltd. (Mochida) has obtained approval of Lexapro® 10 mg (escitalopram) from the Japanese...
Press Releases
Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
Amgen and UCB announced positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody AMG 785/CDP7851 to placebo in postmenopausal women with low...
Press Releases
FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer
Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest...
Press Releases
BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
BioSante Pharmaceuticals, Inc. announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for...
Press Releases
Trophos presents data at the American Academy of Neurology on SMA and MS
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology,...
Press Releases
CIT strengthens services in immunotoxicology
CIT, a leading European CRO specializing in non-clinical health and safety research, is pleased to announce the appointment of a new multi-disciplinary team of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read